Raras
Buscar doenças, sintomas, genes...
Epilepsia de ausências infantil
ORPHA:64280CID-10 · G40.3CID-11 · 8A61.21PCDT · SUSDOENÇA RARA

Uma epilepsia infantil generalizada e familiar, caracterizada por crises de ausência muito frequentes (várias vezes ao dia), que geralmente ocorre em crianças entre 4 e 10 anos de idade e, na maioria dos casos, tem um bom prognóstico.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma epilepsia infantil generalizada e familiar, caracterizada por crises de ausência muito frequentes (várias vezes ao dia), que geralmente ocorre em crianças entre 4 e 10 anos de idade e, na maioria dos casos, tem um bom prognóstico.

Pesquisas ativas
3 ensaios
17 total registrados no ClinicalTrials.gov
Publicações científicas
741 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adolescent
+ childhood
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G40.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
9 sintomas
💪
Músculos
2 sintomas
👁️
Olhos
1 sintomas
🫘
Rins
1 sintomas
👂
Ouvidos
1 sintomas
🦴
Ossos e articulações
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

90%prev.
EEG com complexos de espícula-onda (2,5-3,5 Hz)
Muito frequente (99-80%)
90%prev.
Crise de ausência típica
Muito frequente (99-80%)
55%prev.
Palidez
Frequente (79-30%)
55%prev.
Transtorno do déficit de atenção com hiperatividade
Frequente (79-30%)
17%prev.
Crise tônico-clônica bilateral
Ocasional (29-5%)
17%prev.
Movimentos oculares incontrolados
Ocasional (29-5%)
24sintomas
Muito frequente (2)
Frequente (2)
Ocasional (14)
Muito raro (3)
Sem dados (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 24 características clínicas mais associadas, ordenadas por frequência.

EEG com complexos de espícula-onda (2,5-3,5 Hz)EEG with spike-wave complexes (2.5-3.5 Hz)
Muito frequente (99-80%)90%
Crise de ausência típicaTypical absence seizure
Muito frequente (99-80%)90%
PalidezPallor
Frequente (79-30%)55%
Transtorno do déficit de atenção com hiperatividadeAttention deficit hyperactivity disorder
Frequente (79-30%)55%
Crise tônico-clônica bilateralBilateral tonic-clonic seizure
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico741PubMed
Últimos 10 anos200publicações
Pico202536 papers
Linha do tempo
2026Hoje · 2026🧪 1998Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

GABRA1Gamma-aminobutyric acid receptor subunit alpha-1Candidate gene tested inAltamente restrito
FUNÇÃO

Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:23909897, PubMed:25489750, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GA

LOCALIZAÇÃO

Postsynaptic cell membraneCell membraneCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Epilepsy, childhood absence 4

A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
82.7 TPM
Brain Frontal Cortex BA9
58.5 TPM
Cerebelo
55.7 TPM
Córtex cerebral
31.1 TPM
Brain Anterior cingulate cortex BA24
23.3 TPM
OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 19obsolete Dravet syndromechildhood absence epilepsyjuvenile myoclonic epilepsy
HGNC:4075UniProt:P14867
GABRG2Gamma-aminobutyric acid receptor subunit gamma-2Candidate gene tested inAltamente restrito
FUNÇÃO

Gamma subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:16412217, PubMed:23909897, PubMed:2538761, PubMed:25489750, PubMed:27864268, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit in

LOCALIZAÇÃO

Postsynaptic cell membraneCell membraneCell projection, dendriteCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 74

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE74 is an autosomal dominant form with onset in the first year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
20.3 TPM
Brain Frontal Cortex BA9
19.4 TPM
Cerebelo
15.3 TPM
Córtex cerebral
10.6 TPM
Brain Nucleus accumbens basal ganglia
7.7 TPM
OUTRAS DOENÇAS (7)
febrile seizures, familial, 8developmental and epileptic encephalopathy, 74obsolete Dravet syndromechildhood absence epilepsy
HGNC:4087UniProt:P18507
CACNA1HVoltage-dependent T-type calcium channel subunit alpha-1HCandidate gene tested inTolerante
FUNÇÃO

Voltage-sensitive calcium channel that gives rise to T-type calcium currents. T-type calcium channels belong to the 'low-voltage activated (LVA)' group. A particularity of this type of channel is an opening at quite negative potentials, and a voltage-dependent inactivation (PubMed:27149520, PubMed:9670923, PubMed:9930755). T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle (Probabl

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
NCAM1 interactionsSmooth Muscle ContractionMechanical load activates signaling by PIEZO1 and integrins in osteocytes
MECANISMO DE DOENÇA

Epilepsy, idiopathic generalized 6

A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain.

OUTRAS DOENÇAS (3)
hyperaldosteronism, familial, type IVchildhood absence epilepsyepilepsy, childhood absence, susceptibility to, 6
HGNC:1395UniProt:O95180
JRKJerky protein homologCandidate gene tested inDesconhecido
FUNÇÃO

May bind DNA

LOCALIZAÇÃO

Nucleus

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
14.4 TPM
Fibroblastos
13.5 TPM
Cérebro - Hemisfério cerebelar
13.4 TPM
Ovário
12.3 TPM
Linfócitos
11.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
childhood absence epilepsyjuvenile myoclonic epilepsy
HGNC:6199UniProt:O75564
GABRB3Gamma-aminobutyric acid receptor subunit beta-3Major susceptibility factor inAltamente restrito
FUNÇÃO

Beta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:18514161, PubMed:22243422, PubMed:22303015, PubMed:24909990, PubMed:26950270, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMe

LOCALIZAÇÃO

Postsynaptic cell membraneCell membraneCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Epilepsy, childhood absence 5

A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
21.5 TPM
Cérebro - Hemisfério cerebelar
16.5 TPM
Brain Nucleus accumbens basal ganglia
15.1 TPM
Pituitária
13.8 TPM
Córtex cerebral
13.7 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 43Lennox-Gastaut syndromechildhood absence epilepsyepilepsy, childhood absence, susceptibility to, 5
HGNC:4083UniProt:P28472

Variantes genéticas (ClinVar)

907 variantes patogênicas registradas no ClinVar.

🧬 GABRB3: GRCh38/hg38 15q11.2-13.1(chr15:23387531-28281759)x3 ()
🧬 GABRB3: NM_000814.6(GABRB3):c.328A>C (p.Asn110His) ()
🧬 GABRB3: NM_000814.6(GABRB3):c.743T>G (p.Leu248Arg) ()
🧬 GABRB3: NM_000814.6(GABRB3):c.173-2A>C ()
🧬 GABRB3: NM_000814.6(GABRB3):c.450_451del (p.Tyr151fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 22 variantes classificadas pelo ClinVar.

5
17
VUS (22.7%)
Benigna (77.3%)
VARIANTES MAIS SIGNIFICATIVAS
GABRA6: NM_000811.3(GABRA6):c.255G>C (p.Gln85His) [Uncertain significance]
SCN1B: NM_001037.5(SCN1B):c.85G>A (p.Glu29Lys) [Uncertain significance]
GABRA6: NM_000811.3(GABRA6):c.847A>G (p.Met283Val) [Uncertain significance]
GABRA6: NM_000811.3(GABRA6):c.371C>G (p.Ser124Cys) [Uncertain significance]
GABRA6: NM_000811.3(GABRA6):c.*135C>T [Benign]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 35
2Fase 24
·Pré-clínico6
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 15 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Epilepsia de ausências infantil

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

17 ensaios clínicos encontrados, 3 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
358 papers (10 anos)
#1

Patterns of Response to Treatment and Outcome of Childhood Absence Epilepsy: A Multicenter Study From Saudi Arabia.

Pediatric neurology2026 Mar 06

Childhood absence epilepsy (CAE) is a common pediatric epilepsy syndrome affecting school-aged children. While generally considered benign, recent studies indicate that a significant proportion of patients experience pharmaco-resistance and neuropsychiatric comorbidities. This study aimed to investigate the outcomes of CAE patients across tertiary care centers in Saudi Arabia. A retrospective cohort study was conducted at multiple tertiary care centers in Saudi Arabia. The study included 61 pediatric patients (≤14 years) with confirmed CAE diagnosis. Data were collected from electronic medical records. Response to treatment was defined as >50% reduction in seizure frequency from the baseline, while terminal remission was defined as one-year seizure-free off antiseizure medications. The study population had an equal gender distribution (50.8% male) with a median age of 7 years at diagnosis. Most patients (93.4%) had no comorbidities. The majority (88.5%) achieved response to appropriate antiseizure medications; of these responders, 27.8% achieved terminal remission, while 11.5% demonstrated no response. Isolated staring episodes were the predominant presentation (88.5%). Most patients (93.4%) were managed with monotherapy, with valproic acid (60.7%) being the most commonly prescribed medication, followed by ethosuximide (36.1%). Age at diagnosis showed a positive association with recurrence risk, though not statistically significant. CAE patients in Saudi Arabian tertiary care centers demonstrate favorable outcomes, with high response rates with monotherapy. Early diagnosis and treatment may improve prognosis, as suggested by the trend toward higher recurrence rates in patients diagnosed at older ages.

#2

Deep learning-based real-time seizure detection and multi-seizure classification on pediatric EEG.

Frontiers in neurology2026

To develop a reliable and accurate seizure detection method using deep learning models capable of detecting and classifying multiple seizure types in real time. We retrospectively collected electroencephalography (EEG) recordings, which were acquired as part of routine diagnostic tests for patients aged 3 months to ≤18 years of age with childhood absence epilepsy, infantile epileptic spasms syndrome, other generalized epilepsy, and focal epilepsy, between January 2018 and December 2022 at Severance Children's Hospital. We used EEG recordings from both seizure and non-seizure patients, which were downsampled to 200 Hz for real-time seizure detection and multi-classification. Of the 199 patients (620 seizures), 49 (297 seizures) belonged to the childhood absence epilepsy group, 16 (200 seizures) to the infantile epileptic spasms syndrome group, 14 (76 seizures) to other generalized epilepsy group, 19 (47 seizures) to focal epilepsy group, and 101 to the normal group. The results showed the best overall performance of AUROC 0.98 and APROC of 0.73 with ResNet with Long-Short Term Network and a 12 s sliding window on real-time seizure detection task. Furthermore, ResNet50 without the frequency bands feature extractor showed the best overall weighted performance for multi-class seizure detection with 0.99 AUROC and 0.99 APPRC. Our approach proposes robust methods which include EEG preprocessing strategy with real-time detection/classification of multiple seizures, which helps monitor pediatric seizure. The result shows that real-time seizure detection can be effectively applied to real-world clinical datasets from a pediatric epilepsy unit with realistic performance and speed.

#3

Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study.

Medicine2026 Mar 20

Statins, commonly used lipid-lowering drugs to reduce cardiovascular risk, have also been suggested to have protective effects against epilepsy. However, whether this association is causal remains unclear. We conducted a drug-target Mendelian randomization study to examine the effects of genetically predicted inhibition of 3 established lipid-lowering targets (3-hydroxy-3-methylglutaryl coenzyme A reductase [statins], Niemann-Pick C1-Like 1 [ezetimibe], and proprotein convertase subtilisin/kexin type 9 [PCSK9 inhibitors]) on epilepsy and its subtypes. The inverse-variance weighted approach served as the primary analysis, supplemented with multiple sensitivity tests to ensure robustness. Genetically proxied 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition was associated with decreased risks of epilepsy (odds ratio [OR] = 0.87; 95% confidence interval [CI]: 0.82-0.92; P = 1.4 × 10-6) and focal epilepsy (OR = 0.83; 95% CI: 0.76-0.92; P = 1.5 × 10-4). Inhibition of Niemann-Pick C1-Like 1 corresponded to a lower risk of generalized epilepsy with tonic-clonic seizures (OR = 0.98; 95% CI: 0.97-0.98; P = 1.2 × 10-34) but increased risks of focal epilepsy (lesion negative, OR = 1.08; 95% CI: 1.06-1.09; P = 5.9 × 10-31), childhood absence epilepsy (OR = 1.06; 95% CI: 1.05-1.07; P = 1.8 × 10-21), and juvenile absence epilepsy (OR = 1.03; 95% CI: 1.01-1.05; P = 9.7 × 10-3). PCSK9 inhibition was linked to reduced risks of generalized epilepsy with tonic-clonic seizures (OR = 0.99; 95% CI: 0.98-1.00; P = 1.4 × 10-2), juvenile absence epilepsy (OR = 0.96; 95% CI: 0.93-1.00; P = 2.7 × 10-2), and juvenile myoclonic epilepsy (OR = 0.96; 95% CI: 0.93-1.00; P = 2.9 × 10-2). The effects of lipid-lowering drug targets on epilepsy risk vary by target and exhibit pleiotropy. Statins and PCSK9 inhibitors appear protective against epilepsy and several subtypes, whereas ezetimibe may increase susceptibility to certain subtypes. These results underscore the importance of considering target-specific effects when choosing lipid-lowering therapies for patients with or at risk of epilepsy.

#4

Thalamic distribution and effects of 5-HT2C receptors on tonic GABAA inhibition and absence seizures: implications for treatment.

Frontiers in pharmacology2026

Childhood absence epilepsy (CAE) is associated with abnormal thalamocortical oscillations and enhanced GABAergic function in the ventrobasal (VB) thalamus, including increased extrasynaptic GABAA receptor-mediated tonic currents in thalamocortical (TC) neurons. Serotonin signaling modulates seizure activity in several epilepsy models, and activation of 5-HT2C receptors (5-HT2CRs) has been reported to exert anti-absence seizure effects, although the underlying cellular mechanisms remain unclear. Here, we examined the thalamic distribution of 5-HT2CRs and their functional impact on tonic GABAA inhibition and absence seizures. 5-HT2CR expression in the nucleus reticularis thalami (NRT) and VB was assessed by immunohistochemistry in adult Wistar rats, Genetic Absence Epilepsy Rats from Strasbourg (GAERS), and their non-epileptic control strain (NEC). Whole-cell patch-clamp recordings were used to measure tonic GABAA currents in VB TC neurons in thalamic slices. In vivo EEG recordings in freely moving GAERS rats were performed to evaluate the effects of systemic administration of the 5-HT2CR agonist Ro 60-0175 on absence seizures. No differences in 5-HT2CR expression were observed in the NRT across strains. In the VB, receptor expression was lowest in GAERS and highest in Wistar rats compared with NEC. Tonic GABAA currents in TC neurons were larger in GAERS than in Wistar or NEC rats. Activation of 5-HT2CRs with Ro 60-0175 reduced tonic GABAA currents in TC neurons in all strains. Systemic administration of Ro 60-0175 in adult GAERS produced a clear reduction in absence seizures. These findings indicate that 5-HT2CRs regulate thalamic extrasynaptic GABAA inhibition and that their activation reduces tonic inhibitory drive in TC neurons while exerting anti-absence effects in vivo. The lower expression of 5-HT2CRs in the GAERS VB suggests altered serotonergic control of thalamic inhibition in absence epilepsy. By reducing tonic GABAergic currents, 5-HT2CR activation may rebalance thalamocortical activity and suppress pathological oscillations, supporting these receptors as potential therapeutic targets for CAE.

#5

Isolated absence epilepsy associated with a de novo FBXW7 missense variant in the F-box domain.

Epilepsia open2026 Feb 13

The FBXW7 gene encodes a substrate-recognition component of the Skp1-Cul1-F-box (SCF) E3 ubiquitin ligase complex, which targets key regulatory proteins for proteasomal degradation. Recently, loss-of-function FBXW7 variants have been associated with a novel neurodevelopmental disorder characterized by heterogeneous clinical features. Most reported pathogenic variants cluster within the WD40 domains, while variants in other regions, such as the F-box domain, remain poorly characterized. In this study, we performed trio-exome sequencing on a 3-year-old girl with Early-Onset Childhood Absence Epilepsy. We analyzed the identified FBXW7 variant using multiple in silico tools for pathogenicity prediction and structural modeling. Clinical phenotype was compared with previously reported cases. We identified a novel de novo missense variant in FBXW7, c.926G>C; p.(Arg309Pro), affecting a highly conserved residue in the F-box domain. Notably, unlike prior cases predominantly associated with WD40 domain variants and severe phenotypes, our patient exhibited a much milder clinical presentation consisting of isolated, drug-responsive absence seizures without intellectual disability. Structural modeling predicted significant impairment in protein-protein binding affinity, particularly with the SCF complex component SKP1, supporting a potentially disruptive effect of the p.(Arg309Pro) substitution on complex assembly. Overall, our findings expand the genotypic and phenotypic spectrum of FBXW7-related disorders. Variants in the F-box domain may result in milder neurological phenotypes compared to those in the WD40 domains, suggesting domain-specific effects and potentially distinct pathogenic mechanisms. PLAIN LANGUAGE SUMMARY: The FBXW7 gene helps regulate the stability of many proteins essential for brain development and function. Changes in this gene have recently been linked to neurodevelopmental disorders with epilepsy. We identified a new FBXW7 variant in a 3-year-old girl with early-onset absence epilepsy. Computer-based modeling suggests that this change weakens the protein's normal interactions. Our findings broaden the spectrum of FBXW7-related disorders and indicate that variants in different gene regions may result in variable clinical severity.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC280 artigos no totalmostrando 198

2026

Patterns of Response to Treatment and Outcome of Childhood Absence Epilepsy: A Multicenter Study From Saudi Arabia.

Pediatric neurology
2026

Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study.

Medicine
2026

Deep learning-based real-time seizure detection and multi-seizure classification on pediatric EEG.

Frontiers in neurology
2026

Thalamic distribution and effects of 5-HT2C receptors on tonic GABAA inhibition and absence seizures: implications for treatment.

Frontiers in pharmacology
2026

Isolated absence epilepsy associated with a de novo FBXW7 missense variant in the F-box domain.

Epilepsia open
2025

Computational modeling of resistance to hormone-mediated remission in childhood absence epilepsy.

Frontiers in computational neuroscience
2026

EEG and clinical findings in pediatric epilepsy and control groups using video-based pattern stimulation.

Epileptic disorders : international epilepsy journal with videotape
2026

Bidirectional causal relationships between epilepsy subtypes and psychiatric disorders: A two-sample mendelian randomization study.

Journal of affective disorders
2026

Epilepsy and stroke: A mendelian Randomization study.

Epilepsy research
2025

Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies.

Frontiers in immunology
2026

The whole-brain dynamic neuromagnetic network characteristics in childhood absence epilepsy: A multi-frequency magnetoencephalography study.

Epilepsy &amp; behavior : E&amp;B
2026

Shared and divergent neuromagnetic network signatures in childhood absence epilepsy and self-limited epilepsy with centrotemporal spikes.

Seizure
2026

Clinical and EEG predictors of treatment response in pediatric absence epilepsy - a single-center experience.

Neurologia i neurochirurgia polska
2025

Interruption of rat absence seizures by auditory stimulation.

bioRxiv : the preprint server for biology
2025

Compound heterozygous variants of CACNA1H change channel properties and contribute to intractable epilepsy with myoclonic-atonic seizures.

Journal of human genetics
2025

Childhood absence epilepsy and distinct dynamic functional network connectivity patterns in self-limited epilepsy with centrotemporal spikes: a resting-state fMRI study.

Pediatric research
2026

Syndromic and etiological classification predicts seizure freedom in childhood and youth onset epilepsy: A population-based study from the Norwegian Mother, Father, and Child Cohort Study.

Epilepsia
2025

Investigating the Effects of NMDAR and LGI1 Antibodies on Absence Seizures: Insights from Genetic Absence Epilepsy Rats and Acute Pharmacological Model of Absence Seizures.

Noro psikiyatri arsivi
2025

Increased volumes of the precuneus and the pallidum in idiopathic generalized epilepsy.

Scientific reports
2025

Epilepsy and systemic autoimmune diseases: A bidirectional two-sample Mendelian randomization study.

Epilepsia open
2025

Frontiers in EEG as a tool for the management of pediatric epilepsy: Past, present, and future.

Epilepsia open
2025

Nuclear neuroimaging in childhood epilepsy syndromes: A systematic review.

Epilepsy &amp; behavior : E&amp;B
2025

Impairment of Spatial Working Memory but Preservation of Recognition Memory in Female Rats with Spontaneous Absence Seizures.

Neurochemical research
2025

Associations between the gut microbiota, immune cells, and different subtypes of epilepsy: A Mendelian randomization study.

Epilepsia open
2025

Focus on epilepsy and epilepsy syndromes in children with autism spectrum disorders: a study of 74 patients.

Brain &amp; development
2025

Genome-Wide Insights and Polygenic Risk Scores in Common Epilepsies: A Narrative Review.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2025

Co-occurrence of childhood absence epilepsy and self-limited focal epilepsy interictal discharges: Differences from childhood absence epilepsy alone.

Epileptic disorders : international epilepsy journal with videotape
2025

Ethosuximide Induced Raynaud's Phenomenon in a Child With Childhood Absence Epilepsy.

Journal of child neurology
2025

The Diagnostic Value of EEG Wave Trains for Distinguishing Immature Absence Seizures and Sleep Spindles: Evidence from the WAG/Rij Rat Model.

Diagnostics (Basel, Switzerland)
2025

Physical activity and risk of epilepsy: A 2-sample Mendelian randomization study.

Epileptic disorders : international epilepsy journal with videotape
2025

Immunocyte phenotypes and childhood disease susceptibility: insights from bidirectional Mendelian randomization and implications for immunomodulatory therapies.

Naunyn-Schmiedeberg's archives of pharmacology
2025

Antiseizure potential of the triple T-type calcium channel blocker ACT-709478 (apinocaltamide) in rodent models.

Epilepsia
2025

The noncausal association between a loss-of-function CLCN2 variant and childhood absence epilepsy.

Genomics
2025

Providing integrated mental health care as a neurologist.

Epilepsy &amp; behavior : E&amp;B
2025

Study of Eye Movements Abnormalities in Epilepsy.

Neuro-ophthalmology (Aeolus Press)
2025

Multidimensional dataset for cognitive assessment, sMRI, and rsfMRI in common benign epileptic children.

Scientific data
2025

Video game exposure in children with epilepsy: EEG and clinical findings.

Brain &amp; development
2025

Rhythmic EEG patterns: The oldest idea in the EEG world, but without an obvious definition.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2025

Integrated care for mental health in epilepsy: A systematic review and meta-synthesis by the International League Against Epilepsy Integrated Mental Health Care Pathways Task Force.

Epilepsia
2025

Tremor as an intrinsic feature of juvenile myoclonic epilepsy.

Epilepsia
2025

Molecular and clinical Insights into KMT2E-Related O'Donnell-Luria-Rodan syndrome in a novel patient cohort.

European journal of medical genetics
2025

Modelling the effect of allopregnanolone on the resolution of spike-wave discharges.

Journal of computational neuroscience
2025

Clinical, etiological, and therapeutic profile of early-onset absence seizures: A case series analysis.

Clinical neurology and neurosurgery
2025

Assessing the Need for Repeat EEG in Pediatric Patients with Idiopathic Generalized Epilepsy After Anti-Seizure Medication Withdrawal Following Seizure Freedom.

Journal of child neurology
2024

Metabolite Associations with Childhood and Juvenile Absence Epilepsy: A Bidirectional Mendelian Randomization Study.

Psychiatry and clinical psychopharmacology
2025

Whole-course power evolution in childhood absence epilepsy: A multi-frequency magnetoencephalography study.

Seizure
2024

Genetic heterogeneity in familial forms of genetic generalized epilepsy: from mono- to oligogenism.

Human genomics
2025

WONOEP appraisal: Targeted therapy development for early onset epilepsies.

Epilepsia
2024

Should neurologists treat common psychiatric comorbidities in patients with epilepsy?

Epilepsy &amp; behavior reports
2024

Risk of ADHD in children with childhood absence epilepsy versus controls: A population-based study.

Epilepsy &amp; behavior : E&amp;B
2025

A unique case of tactile-induced reflex myoclonic epilepsy of infancy evolving into childhood absence epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2024

Unraveling the shared genetics of common epilepsies and general cognitive ability.

Seizure
2024

Generalized spike-waves in idiopathic generalized epilepsies: Does their frequency matter?

Brain and behavior
2024

Molecular Mechanisms Underlying the Generation of Absence Seizures: Identification of Potential Targets for Therapeutic Intervention.

International journal of molecular sciences
2024

A Review of Hyperventilation Activation in Diagnosis and Management of Childhood Absence Epilepsy.

Journal of child neurology
2024

Causal links between serum micronutrients and epilepsy: a Mendelian randomization analysis.

Frontiers in neurology
2024

A novel duplication mutation of SLC2A1 gene causing glucose transporter 1 deficiency syndrome.

Gene
2024

Importance of Genetic Testing in Children With Generalized Epilepsy.

Cureus
2024

Assessing the impact of circulating inflammatory cytokines and proteins as drivers and therapeutic targets in epilepsy: A Mendelian randomization study.

Epilepsy &amp; behavior : E&amp;B
2024

Dissecting the Shared Genetic Architecture of Common Epilepsies With Cortical Brain Morphology.

Neurology. Genetics
2024

Glucose transporter-1 deficiency syndrome with extreme phenotypic variability in a five-generation family carrying a novel SLC2A1 variant.

European journal of neurology
2024

Detection of seizure onset in childhood absence epilepsy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2024

Focality in childhood absence epilepsy.

Neurological research
2024

A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME).

PloS one
2024

A 6-year-old with childhood absence epilepsy and motor hyperactivity.

Epilepsy &amp; behavior reports
2024

Epilepsy-related functional brain network alterations are already present at an early age in the GAERS rat model of genetic absence epilepsy.

Frontiers in neurology
2024

Drug-resistant generalized epilepsies: Revisiting the frontiers of idiopathic generalized epilepsies.

Revue neurologique
2024

Long-term Prognosis of Childhood Absence Epilepsy.

Noro psikiyatri arsivi
2024

Care of pharmaco-resistant absence seizures in childhood.

Revue neurologique
2025

Association of epilepsy and neurological impairments with homozygous recessive missense mutations found in the genes responsible for ganglioside biosynthesis (ST3GAL5) and calcium voltage-gated channels (CACNA1H) - insights through molecular dynamic simulations.

Journal of biomolecular structure &amp; dynamics
2023

Thyroid function and epilepsy: a two-sample Mendelian randomization study.

Frontiers in human neuroscience
2024

The sound of silence: Quantification of typical absence seizures by sonifying EEG signals from a custom-built wearable device.

Epileptic disorders : international epilepsy journal with videotape
2024

The Challenges of Distinguishing Cognitive Disengagement Syndrome from Childhood Absence Epilepsy in Clinical Settings.

Developmental neuropsychology
2024

Predicting the therapeutic response to valproic acid in childhood absence epilepsy through electroencephalogram analysis using machine learning.

Epilepsy &amp; behavior : E&amp;B
2023

Dysfunction of the glymphatic system in childhood absence epilepsy.

Frontiers in neuroscience
2023

Exploring the core network of the structural covariance network in childhood absence epilepsy.

Heliyon
2024

Lack of causal association between epilepsy and dementia: A Mendelian randomization analysis.

Epilepsy &amp; behavior : E&amp;B
2024

Exploring causal correlations between systemic inflammatory cytokines and epilepsy: A bidirectional Mendelian randomization study.

Seizure
2024

Childhood Absence Epilepsy- Electroclinical Profile and Prevalence of Attention-Deficit/Hyperactivity Disorder Among a Cohort of 47 Children.

Pediatric neurology
2023

Efficacy of highly purified cannabidiol (CBD) in typical absence seizures: A pilot study.

Epilepsy &amp; behavior : E&amp;B
2024

W. J. Adie and his "pyknolepsy," a century ago.

Journal of the history of the neurosciences
2023

Differences in generation and maintenance between ictal and interictal generalized spike-and-wave discharges in childhood absence epilepsy: A magnetoencephalography study.

Epilepsy &amp; behavior : E&amp;B
2023

[Idiopathic generalized epilepsies].

Medicina
2023

Relationship Between Electroencephalography and Seizure Outcome in Typical Absence Seizures in Children.

Pediatric neurology
2024

A quantitative and T-pattern analysis of anxiety-like behavior in male GAERS, NEC, and Wistar rats bred under the same conditions, against a commercially available Wistar control group in the hole board and elevated plus maze tests.

CNS neuroscience &amp; therapeutics
2023

Variation in functional networks between clinical and subclinical discharges in childhood absence epilepsy: A multi-frequency MEG study.

Seizure
2023

Patient-derived SLC6A1 variant S295L results in an epileptic phenotype similar to haploinsufficient mice.

Epilepsia
2023

Changes in awake and sleep electroencephalography characteristics after 1-year treatment for childhood and juvenile absence epilepsy.

Seizure
2023

EEG phase synchronization during absence seizures.

Frontiers in neuroinformatics
2023

Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis.

Journal of neurology
2023

Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy.

Clinical pharmacology and therapeutics
2023

Impaired rich-club connectivity in childhood absence epilepsy.

Frontiers in neurology
2023

Alzheimer Disease and Epilepsy: A Mendelian Randomization Study.

Neurology
2023

Knowledge and Awareness of Parents About the Difference Between Attention Deficit Hyperactivity Disorder and Childhood Absence Epilepsy in the Paediatric Population Makkah, Saudi Arabia: A Cross-Sectional Study.

Cureus
2023

Altered neuromagnetic activity in default mode network in childhood absence epilepsy.

Frontiers in neuroscience
2023

HCN channels and absence seizures.

Neurobiology of disease
2023

Clinical and electroencephalographic findings prior to the onset of juvenile myoclonic epilepsy: A case series.

Epileptic disorders : international epilepsy journal with videotape
2023

Three consecutive epilepsy syndromes in one child.

Epileptic disorders : international epilepsy journal with videotape
2024

Does E-learning Facilitate Medical Education in Pediatric Neurology?

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2024

Clinical application of trio-based whole-exome sequencing in idiopathic generalized epilepsy.

Seizure
2023

Childhood absence epilepsy patients with cognitive impairment have decreased sleep spindle density.

Sleep medicine
2023

Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members.

Epilepsia open
2023

Developmental Inhibitory Changes in the Primary Somatosensory Cortex of the Stargazer Mouse Model of Absence Epilepsy.

Biomolecules
2023

Suppression of seizure in childhood absence epilepsy using robust control of deep brain stimulation: a simulation study.

Scientific reports
2023

School performance and psychiatric comorbidity in childhood absence epilepsy: A Danish cohort study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2023

An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup.

Pharmacology research &amp; perspectives
2022

Genetically proxied gut microbiota, gut metabolites with risk of epilepsy and the subtypes: A bi-directional Mendelian randomization study.

Frontiers in molecular neuroscience
2022

Causal relationship among obesity and body fat distribution and epilepsy subtypes.

Frontiers in neurology
2023

Neuronal networks underlying ictal and subclinical discharges in childhood absence epilepsy.

Journal of neurology
2022

Clinical and Instrumental Follow-Up of Childhood Absence Epilepsy (CAE): Exploration of Prognostic Factors.

Children (Basel, Switzerland)
2022

EEG Markers of Treatment Resistance in Idiopathic Generalized Epilepsy: From Standard EEG Findings to Advanced Signal Analysis.

Biomedicines
2022

A Case of a Seven-Year-old boy with Epilepsy with Myoclonic Absence: Importance of Seizure Semiology, Genetic Etiology, and Electroencephalogram Correlation for Timely Intervention.

Child neurology open
2022

Childhood vs. juvenile absence epilepsy: How to make a diagnosis.

Seizure
2022

Childhood Absence Epilepsy Associated With Concomitant Centrotemporal Spikes.

Cureus
2022

The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membranes.

Cells
2022

Temporal and spatial dynamic propagation of electroencephalogram by combining power spectral and synchronization in childhood absence epilepsy.

Frontiers in neuroinformatics
2022

Perampanel and childhood absence epilepsy: A real life experience.

Frontiers in neurology
2023

Idiopathic generalized epilepsies: Analysis of 101 patients.

Medicina clinica
2022

Pretreatment electroencephalographic features in patients with childhood absence epilepsy.

Neurophysiologie clinique = Clinical neurophysiology
2022

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design.

Epilepsia open
2022

Staring Spells: How to Distinguish Epileptic Seizures from Nonepileptic Staring.

Journal of child neurology
2022

PRRT2 mutation in a Japanese woman: Adult-onset focal epilepsy coexisting with movement disorders and cerebellar atrophy.

Epilepsy &amp; behavior reports
2022

Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats.

Frontiers in cellular neuroscience
2022

Childhood absence epilepsy: Electro-clinical manifestations, treatment options, and outcome in a tertiary educational center.

International journal of pediatrics &amp; adolescent medicine
2022

CACNA1A Mutations Associated With Epilepsies and Their Molecular Sub-Regional Implications.

Frontiers in molecular neuroscience
2022

International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.

Epilepsia
2022

ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions.

Epilepsia
2022

Validation of Pediatric Idiopathic Generalized Epilepsy Diagnoses from the Danish National Patient Register During 1994‒2019.

Clinical epidemiology
2022

Pretreatment topological disruptions of whole-brain networks exist in childhood absence epilepsy: A resting-state EEG-fMRI study.

Epilepsy research
2022

Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.

Neurologia
2022

The Impact of Glutamatergic Synapse Dysfunction in the Corticothalamocortical Network on Absence Seizure Generation.

Frontiers in molecular neuroscience
2022

The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.

IBRO neuroscience reports
2022

Neuropsychological and behavioral profiles of self-limited epileptic syndromes of childhood: a cross-syndrome comparison.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence
2022

Sleep disorders and ADHD symptoms in children and adolescents with typical absence seizures: An observational study.

Epilepsy &amp; behavior : E&amp;B
2021

Therapeutic Options for Childhood Absence Epilepsy.

Pediatric reports
2022

Absence seizures during sleep in childhood absence epilepsy: A sign of drug resistance?

Brain &amp; development
2022

Genetic generalized epilepsies in adults - challenging assumptions and dogmas.

Nature reviews. Neurology
2021

Frequency-Dependent Dynamics of Functional Connectivity Networks During Seizure Termination in Childhood Absence Epilepsy: A Magnetoencephalography Study.

Frontiers in neurology
2021

Involvement of ADGRV1 Gene in Familial Forms of Genetic Generalized Epilepsy.

Frontiers in neurology
2021

More than one self-limited epilepsy of childhood in the same patient: A multicenter study.

Epilepsy research
2021

Pretreatment Source Location and Functional Connectivity Network Correlated With Therapy Response in Childhood Absence Epilepsy: A Magnetoencephalography Study.

Frontiers in neurology
2021

Alterations in white matter integrity and asymmetry in patients with benign childhood epilepsy with centrotemporal spikes and childhood absence epilepsy: An automated fiber quantification tractography study.

Epilepsy &amp; behavior : E&amp;B
2022

Cross-Frequency Coupling in Childhood Absence Epilepsy.

Brain connectivity
2021

Graph-theory based degree centrality combined with machine learning algorithms can predict response to treatment with antiepileptic medications in children with epilepsy.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2021

Differentiating ictal/subclinical spikes and waves in childhood absence epilepsy by spectral and network analyses: A pilot study.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2021

Association Analysis of Candidate Variants in Admixed Brazilian Patients With Genetic Generalized Epilepsies.

Frontiers in genetics
2021

Impact of Dysfunctional Feed-Forward Inhibition on Glutamate Decarboxylase Isoforms and γ-Aminobutyric Acid Transporters.

International journal of molecular sciences
2021

Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes.

Expert review of clinical pharmacology
2021

Absence Seizure Detection Algorithm for Portable EEG Devices.

Frontiers in neurology
2021

Topological Organization Alterations of Whole-Brain Functional Networks in Patients with Childhood Absence Epilepsy: Associations with Treatment Effects.

Disease markers
2021

Functional reorganization of brain regions into a network in childhood absence epilepsy: A magnetoencephalography study.

Epilepsy &amp; behavior : E&amp;B
2021

Epilepsy: Epileptic Syndromes and Treatment.

Neurologic clinics
2021

From Physiology to Pathology of Cortico-Thalamo-Cortical Oscillations: Astroglia as a Target for Further Research.

Frontiers in neurology
2021

Identification of a novel variant p.Ser606Gly in SCN3A associated with childhood absence epilepsy.

Epilepsy research
2021

Assessing seizure burden in pediatric epilepsy using an electronic medical record-based tool through a common data element approach.

Epilepsia
2021

Altered Neurotransmitter Expression in the Corticothalamocortical Network of an Absence Epilepsy Model with impaired Feedforward Inhibition.

Neuroscience
2021

Seizures in Sotos syndrome: Phenotyping in 49 patients.

Epilepsia open
2021

Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons.

Brain : a journal of neurology
2021

Systemic administration of ivabradine, a hyperpolarization-activated cyclic nucleotide-gated channel inhibitor, blocks spontaneous absence seizures.

Epilepsia
2021

Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.

Neuropharmacology
2021

Absence seizures and their relationship to depression and anxiety: Evidence for bidirectionality.

Epilepsia
2021

Clinical profile and treatment outcome of epilepsy syndromes in children: A hospital-based study in Eastern Nepal.

Epilepsia open
2021

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.

The Cochrane database of systematic reviews
2021

Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE).

Seizure
2021

Diagnosing and managing childhood absence epilepsy by telemedicine.

Epilepsy &amp; behavior : E&amp;B
2020

Changes of Ictal-Onset Epileptic Network Synchronicity in Childhood Absence Epilepsy: A Magnetoencephalography Study.

Frontiers in neurology
2020

Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.

International journal of molecular sciences
2020

The brain as a complex network: assessment of EEG-based functional connectivity patterns in patients with childhood absence epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2020

Network characteristics of genetic generalized epilepsy: Are the syndromes distinct?

Seizure
2020

Altered Structural Network in Newly Onset Childhood Absence Epilepsy.

Journal of clinical neurology (Seoul, Korea)
2020

Dynamical mesoscale model of absence seizures in genetic models.

PloS one
2020

How to diagnose and classify idiopathic (genetic) generalized epilepsies.

Epileptic disorders : international epilepsy journal with videotape
2020

Trait impulsivity correlates with active myoclonic seizures in genetic generalized epilepsy.

Epilepsy &amp; behavior : E&amp;B
2020

Multifrequency Dynamics of Cortical Neuromagnetic Activity Underlying Seizure Termination in Absence Epilepsy.

Frontiers in human neuroscience
2020

Cortical and subcortical volume differences between Benign Epilepsy with Centrotemporal Spikes and Childhood Absence Epilepsy.

Epilepsy research
2020

Genetic generalized epilepsies with frontal lesions mimicking migratory disorders on the epilepsy monitoring unit.

Epilepsia open
2020

Idiopathic (genetic) generalized epilepsies with absences: clinical and electrographic characteristics and seizure outcome.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2020

NUS1 mutation in a family with epilepsy, cerebellar ataxia, and tremor.

Epilepsy research
2020

Characterization of Anti-seizure Medication Treatment Pathways in Pediatric Epilepsy Using the Electronic Health Record-Based Common Data Model.

Frontiers in neurology
2020

Absence seizure provocation during routine EEG: Does position of the child during hyperventilation affect the diagnostic yield?

Seizure
2020

Does Early Recognition of Treatment Failure and Changing Anti-Epilepsy Medication Regimen Improve Short-Term Seizure Remission Rates In Childhood Absence Epilepsy?

Acta neurologica Taiwanica
2020

Circadian Rhythms and Epilepsy: A Suitable Case for Absence Epilepsy.

Frontiers in neurology
2020

Functional brain network characteristics are associated with epilepsy severity in childhood absence epilepsy.

NeuroImage. Clinical
2020

Altered spontaneous brain activity in patients with childhood absence epilepsy: associations with treatment effects.

Neuroreport
2020

Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls.

Frontiers in pharmacology
2020

High-power, frontal-dominant ripples in absence status epilepticus during childhood.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2020

Constructing an Axonal-Specific Myelin Developmental Graph and its Application to Childhood Absence Epilepsy.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
2020

Changes in Interictal Pretreatment and Posttreatment EEG in Childhood Absence Epilepsy.

Frontiers in neuroscience
2020

CACNA1H variants are not a cause of monogenic epilepsy.

Human mutation
2020

Cognitive Function in Genetic Generalized Epilepsies: Insights From Neuropsychology and Neuroimaging.

Frontiers in neurology
2020

Spike-wave discharges in absence epilepsy: segregation of electrographic components reveals distinct pathways of seizure activity.

The Journal of physiology
2019

Differences Between Interictal and Ictal Generalized Spike-Wave Discharges in Childhood Absence Epilepsy: A MEG Study.

Frontiers in neurology
2020

Identifying epilepsy psychiatric comorbidities with machine learning.

Acta neurologica Scandinavica
2020

Default mode network dysfunction in idiopathic generalised epilepsy.

Epilepsy research
2020

Infantile spasms followed by childhood absence epilepsy: A case series.

Seizure
2020

Adult loss of Cacna1a in mice recapitulates childhood absence epilepsy by distinct thalamic bursting mechanisms.

Brain : a journal of neurology
2019

Genomic and Personalized Medicine Perspective in Genetic Generalized Epilepsy.

Archives of Iranian medicine
2019

[Pathomorphosis of idiopathic generalized epilepsies].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Ver todos os 280 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Epilepsia de ausências infantil.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Epilepsia de ausências infantil

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Patterns of Response to Treatment and Outcome of Childhood Absence Epilepsy: A Multicenter Study From Saudi Arabia.
    Pediatric neurology· 2026· PMID 41875828mais citado
  2. Deep learning-based real-time seizure detection and multi-seizure classification on pediatric EEG.
    Frontiers in neurology· 2026· PMID 41809189mais citado
  3. Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study.
    Medicine· 2026· PMID 41861198mais citado
  4. Thalamic distribution and effects of 5-HT2C receptors on tonic GABAA inhibition and absence seizures: implications for treatment.
    Frontiers in pharmacology· 2026· PMID 41800091mais citado
  5. Isolated absence epilepsy associated with a de novo FBXW7 missense variant in the F-box domain.
    Epilepsia open· 2026· PMID 41685408mais citado
  6. Circuit-Selective FAAH Inhibition Suppresses Experimental Absence Seizures.
    CNS Neurosci Ther· 2026· PMID 41969140recente
  7. Presynaptic P/Q calcium channel deficit promotes postsynaptic excitability remodeling and neurogenesis in developing thalamic circuitry.
    Neuron· 2026· PMID 41932329recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:64280(Orphanet)
  2. MONDO:0010826(MONDO)
  3. Epilepsia(PCDT · Ministério da Saúde)
  4. GARD:16667(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q2894827(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Epilepsia de ausências infantil
Compêndio · Raras BR

Epilepsia de ausências infantil

ORPHA:64280 · MONDO:0010826
🇧🇷 Brasil SUS
Geral
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
G40.3 · Epilepsia e síndromes epilépticas generalizadas idiopáticas
CID-11
Ensaios
3 ativos
Início
Adolescent, Childhood
Prevalência
0.0 (Europe)
MedGen
UMLS
C0014553
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades